| 000 | 01423 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514160836.0 | ||
| 264 | 0 | _c20040519 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a0268-1315 | ||
| 024 | 7 |
_a10.1097/00004850-200311000-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSacchetti, E | |
| 245 | 0 | 0 |
_aQuetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. _h[electronic resource] |
| 260 |
_bInternational clinical psychopharmacology _cNov 2003 |
||
| 300 |
_a357-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAmphetamine-Related Disorders _xcomplications |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzodiazepines _xadverse effects |
| 650 | 0 | 4 |
_aClozapine _xadverse effects |
| 650 | 0 | 4 |
_aDibenzothiazepines _xadverse effects |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHaloperidol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 | _aQuetiapine Fumarate |
| 650 | 0 | 4 |
_aSchizophrenia, Paranoid _xcomplications |
| 700 | 1 | _aValsecchi, P | |
| 773 | 0 |
_tInternational clinical psychopharmacology _gvol. 18 _gno. 6 _gp. 357-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004850-200311000-00008 _zAvailable from publisher's website |
| 999 |
_c14313655 _d14313655 |
||